Use of Rituximab in autoimmune hemolytic anemia associated with non-hodgkin lymphomas [PDF]
, 2011 The association between non-Hodgkin lymphomas and autoimmune disorders is a well-known event. Also autoimmune hemolytic anemia (AHA), although much more frequent in patients with chronic lymphocytic leukemia (CLL), has been described in this group of ...
Fozza, Claudio +1 more
core +4 more sources
Diagnosis and Management of Autoimmune Hemolytic Anemia in Patients with Liver and Bowel Disorders
Journal of Clinical Medicine, 2021 Anemia is a common feature of liver and bowel diseases. Although the main causes of anemia in these conditions are represented by gastrointestinal bleeding and iron deficiency, autoimmune hemolytic anemia should be considered in the differential ...
C. Bianco +3 more
semanticscholar +1 more source
Diagnostic and therapeutic considerations in idiopathic hypereosinophilia with warm autoimmune hemolytic anemia. [PDF]
, 2015 Hypereosinophilic syndrome (HES) encompasses numerous diverse conditions resulting in peripheral hypereosinophilia that cannot be explained by hypersensitivity, infection, or atopy and that is not associated with known systemic diseases with specific ...
Brys, Adam K +3 more
core +1 more source
Anemia hemolítica autoimune e colite ulcerosa.
Acta Médica Portuguesa, 1995 Although several associations of autoimmune disorders with ulcerative colitis have been reported, autoimmune hemolytic anemia is extremely rare. We report a case of a 35 year-old white woman with a twelve-year history of mild ulcerative colitis treated ...
L Rebocho, M Lucas, R M Victorino
doaj +1 more source
Clinical relevance of silent red blood cell autoantibodies. [PDF]
, 2017 .
Alessandri, C +14 more
core +1 more source
The Changing Landscape of Autoimmune Hemolytic Anemia
Frontiers in Immunology, 2020 Autoimmune hemolytic anemia (AIHA) is a greatly heterogeneous disease due to autoantibodies directed against erythrocytes, with or without complement activation.
W. Barcellini, B. Fattizzo
semanticscholar +1 more source
A Case of Autoimmune Hemolytic Anemia Following COVID-19 Messenger Ribonucleic Acid Vaccination
Cureus, 2021 Autoimmune hemolytic anemia (AIHA) is a condition characterized by the increased destruction of red blood cells (RBCs) mediated by anti-erythrocyte autoantibodies with or without complement activation.
Sérgio Brito +6 more
semanticscholar +1 more source
Problem of the diagnosis of acquired hemolytic anemia in childhood
Zdorovʹe Rebenka, 2020 Autoimmune hemolytic anemia is a heterogeneous group of diseases that are associated with decompensated acquired hemolysis. Autoimmune hemolytic anemia in children is most commonly observed after a viral illness. However, it is quite a rare disorder with
S.O. Nykytyuk +4 more
doaj +1 more source
New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
Journal of Clinical Medicine, 2020 Autoimmune hemolytic anemia (AIHA) is a highly heterogeneous disease due to increased destruction of autologous erythrocytes by autoantibodies with or without complement involvement. Other pathogenic mechanisms include hyper-activation of cellular immune
W. Barcellini +3 more
semanticscholar +1 more source
Infantile Cytomegalovirus-Associated Severe Warm Autoimmune Hemolytic Anemia: A Case Report
Children, 2017 Autoimmune hemolytic anemia is a rare hematologic entity in children. Etiologies are mainly viruses or bacteria. We describe here a case of severe warm autoimmune hemolytic anemia (IgG- and C3d-positive direct antiglobulin test) in an immunocompetent 6 ...
Hassan K. Khalifeh +2 more
doaj +1 more source